Catalyst Capital Advisors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-300,000
Closed -$203K – 633
2015
Q1
$203K Hold
300,000
– – 0.02% 278
2014
Q4
$237K Buy
300,000
+68,200
+29% +$46.6K 0.03% 296
2014
Q3
$108K Hold
231,800
– – 0.01% 315
2014
Q2
$116K Buy
231,800
+156,800
+209% +$75.8K 0.02% 318
2014
Q1
$24K Hold
75,000
– – 0.01% 308
2013
Q4
$26K Sell
75,000
-5,000
-6% -$6.04K 0.01% 252
2013
Q3
$162K Hold
80,000
– – 0.09% 231
2013
Q2
$154K Buy
+80,000
New +$141K 0.12% 191

Other funds holding GCVRZ

Catalyst Capital Advisors's GCVRZ Position: Q2 2015 in Review

Catalyst Capital Advisors sold out of Sanofi Contingent Value Rights (GCVRZ) in Q2 2015, closing a stake of 300,000 shares — an estimated $203K sold.

Catalyst Capital Advisors first reported a position in GCVRZ in Q2 2013 and held it in 8 quarters. The position peaked at $237K in Q4 2014. 116 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2015.

  • Catalyst Capital Advisors reported no remaining Sanofi Contingent Value Rights position as of Q2 2015 after selling out during the quarter.
  • Catalyst Capital Advisors sold 300,000 Sanofi Contingent Value Rights shares in Q2 2015, an estimated $203K.
  • Catalyst Capital Advisors first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 8 quarters.
  • Catalyst Capital Advisors's Sanofi Contingent Value Rights position peaked at $237K in Q4 2014.
  • 116 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2015.

Based on Catalyst Capital Advisors's 13F filing for Q2 2015, filed 12 Aug 2015.